Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
摘要：
In the 1950s and 1960s, it became apparent that elevated concentrations of plasma cholesterol were a major risk factor for the development of coronary heart disease, which led to the search for drugs that could reduce plasma cholesterol. One possibility was to reduce cholesterol biosynthesis, and the rate-limiting enzyme in the cholesterol biosynthetic pathway, 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase, was a natural target. Here, I describe the discovery and development of lovastatin--the first approved inhibitor of HMG-CoA reductase--and the clinical trials that have provided the evidence for the ability of drugs in this class to reduce the morbidity and mortality associated with cardiovascular disease.
展开
DOI：
10.1038/nrd1112
被引量：
年份：
2003
Taylor & Francis
Springer
Nature
Nature
(全网免费下载)
万方医学
查看更多
dx.doi.org
Oxford Univ Press
Europe PMC
NCBI
NCBI
The Lancet
ResearchGate
ProQuest
EBSCO
EBSCO
readcube.com
clinchem.org
plantphysiol.org
emboj.embopress.org
mendeley.com
jaha.ahajournals.org
mcponline.org
jlr.org
en.zl50.com
ftp.palgrave-journals.com
onAcademic
aem.asm.org
cshperspectives.cshlp.org
molbiolcell.org
SAGE
science-open.com
deepdyve.com
mysciencework.com
reviews.jbjs.org
aaojournal.org
molpharm.aspetjournals.org
pherobase.com
jimmunol.org
jasn.asnjournals.org
www2.uni-frankfurt.de
(全网免费下载)
greatneck.k12.ny.us
(全网免费下载)
www.socolar.com
pharm.unipmn.it
(全网免费下载)
uni-frankfurt.de
(全网免费下载)
Nature
(全网免费下载)
www2.uni-frankfurt.de
(全网免费下载)
greatneck.k12.ny.us
(全网免费下载)
pharm.unipmn.it
(全网免费下载)
uni-frankfurt.de
(全网免费下载)
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
